Hypothesizing that control over ICAM-1 expression should prevent the earliest stages of retinopathy, the authors applied small-interfering RNA (siRNAs) through a hydrodynamics-based transfection technique (HT) and intravitreal injection (IV) to a murine retina in vivo. Here, ICAM1 is linked to retinal disorder.